This trend is amplified with increasing remoteness for most acute and chronic conditions with the NT having the highest rate of avoidable hospitalizations in Australia (47.8/1000 persons). 2 In the NT, the cost of aeromedical evacuations is borne by the NT Department of Health, which quotes a cost of $141.59 per minute flight time in its Fees and Charges Manual. 3 For a 1-hour return medical retrieval, this equates to a total cost of $8,495 per evacuation. This figure is consistent with published data from rural and remote Queensland aeromedical evacuations of $8,520 per 1-hour interhospital transfer. 4 The cost of medical evacuations via helicopter is substantially higher at $16,171 per 1-hour return flight. 3 The CareFlight 2014/15 Annual Report documented a total of 2789 emergency evacuations for the Top End of the NT (111 [4%] of which were via helicopter), 5 based on an average 2-hour return flight; this equates to an annual cost estimate of $47 million dollars per annum for the Top End jurisdiction alone. Rural and remote disadvantage is also reflected in poorer standards of general services and health infrastructure including pathology services. Point-of-care testing (POCT) allows pathology testing to be conducted during a patient visit with results immediately available for patient care. 6 POCT has a particular niche in rural and remote communities where access to mainstream laboratory services is generally poor, there are long delays in transporting pathology samples to laboratories, turnaround time for delivery of test results back to the local health service may be slow, and patient loss to follow-up is high. 7, 8 For medical emergencies in these sectors, the speed of POCT provides critical practical and operational benefits by providing another tool to assist in the triage of acutely ill patients. The additional clinical information provided by POCT adds valuable data within the patient assessment. These extra data reduce the intrinsic risk implied by deciding to leave a patient in a community, with its lower level of available clinical care. POCT also identifies patients at high risk but an absence of clinical signs (eg, a patient clinically stable post infarct).
POCT is considered to be generally more expensive than traditional laboratory pathology testing as it is not able to achieve the same economy of scale. [9] [10] [11] However, a limited number of studies have examined the cost effectiveness of POCT in a rural or remote context. One previous study based on data from a hospital in rural New Zealand demonstrated that POCT improved diagnostic certainty and thereby reduced the number of transfers to the major base hospital by 62% and increased weekly discharges from seven pre-POCT to 34 post-POCT, with associated cost savings of NZ$362,138 per annum. 12 Previous studies from our research group have evaluated the analytical safety, operational efficiency, and clinical effectiveness of the i-STAT (Abbott Point of Care, Princeton, NJ, USA) POCT device in the primary care setting in remote NT. [13] [14] [15] [16] The use of the i-STAT device in the remote NT includes tests for cardiac troponin I, electrolytes, blood gases, urea, creatinine, glucose, ionized calcium, and international normalized ratio (INR) with results for each test available in 10 minutes or less. The present study from our group is the first to provide an economic evaluation of POCT on the i-STAT for acute presentations in this setting. Our hypothesis is that POCT will prevent unnecessary medical evacuations and thereby lead to cost savings. Unnecessary evacuations were defined as the number of evacuations that would have taken place in the absence of POCT results, that is, based solely on clinical interpretation, basic medical equipment, and discussion with an on-call off-site medical practitioner. This analysis took the form of a model-based probabilistic economic evaluation assessing whether POCT leads to costs savings through preventing unnecessary medical retrievals when compared to usual care.
Methods

Site selection
In Australia's NT, remote health care is provided through primary health care facilities that have limited infrastructure, resources, and staffing levels, with high rates of staff turnover. These remote health facilities are generally located many hundreds of kilometers from the nearest major tertiary hospital, necessitating air transport as the best (and often only) option for acutely ill patients.
Six remote health services in the NT that have access to on-site POCT (and were current participants in the NT i-STAT POCT Program) were selected to evaluate the clinical and cost effectiveness of the management of acute patient presentations. The six remote health centers comprised two large centers (servicing an indigenous population base of between 2000 and 3000 clients), two medium-sized centers (~1000 clients), and two small centers (<500 clients). Two of the health centers were located in the Central Australian region (which covers the southern half of the NT which 
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POCT in remote Australian NT primary health care sector comprises a mainly desert environment) and four were from the Top End of the NT (which comprised the tropical northern half of the Territory).
Acute presentations
The economic evaluation in this study focused on three common acute presentations observed in the NT: chest pain or other symptoms suggestive of acute coronary syndrome (ACS) with no obvious ST-elevation on electrocardiogram (ECG); symptoms resulting from missed dialysis session(s) in the setting of chronic renal failure (CRF); and symptoms suggestive of acute dehydration due to diarrhea and/or vomiting. A detailed description of the normal pathways for each acute condition and how POCT changes these pathways was provided in a separate paper by our research group, which outlined the clinical effectiveness of POCT. 15 The i-STAT tests investigated in this study were troponin I for ruling out ACS; potassium and creatinine to measure CRF patient risk; and sodium, potassium, and chloride for assessing possible acute dehydration.
Adverse events
To determine if patients who remained in the remote communities experienced any adverse events, the electronic case notes within the Patient Care Information System (PCIS) were examined for each patient 10 days after their initial presentation. Adverse events included any secondary acute presentation, a medical evacuation, or death.
Ethics registration
Data on the prevalence of the three presentation types in patients serviced by the remote health center network of the NT Department of Health were sourced from the NT Health Data Warehouse (NTHDW), requiring the investigators to gain ethics approval for this project from the Menzies School of Health Research Ethics Committee (Application Number 2015-2469, approved September 2015). A data release application form for NTHDW was also lodged in November 2015 and approved on May 20, 2016 . A condition of ethics approval was that all remote community and individual patient identities must be kept anonymous.
Development of the economic evaluation model
A decision analytic simulation model (DASM) or "Decision Tree" 17, 18 was used to assess whether POCT leads to cost savings compared to usual care in the three separate acute medical presentations outlined above. A modeling framework is ideally suited to demonstrate and explore the importance of the inherent uncertainty in the cost-effectiveness question. 19 In the POCT arm, the decision to medically evacuate a patient was made on the basis of on-site i-STAT results from the participating remote health centers. In the usual care arm, the project's Chief Clinical Investigator (Senior Rural Medical Practitioner in the NT) provided an independent clinical judgment on whether each patient would or would not have been evacuated to hospital should the results from the i-STAT device not have been available at the time of the presentation. This decision was based on clinical interpretation, results of basic medical equipment tests, and review of the patient's electronic record. This process is exactly the way clinical decisions about evacuations were made routinely prior to POCT being available at all sites, with the Clinical Advisor having considerable experience in these decisionmaking processes, both before and after the introduction of POCT in the NT.
Model structures and inputs
The structures of the DASM for each condition are shown in Figure 1 . The pathways for the modeled acute presentations within the POCT and usual care arms were designed to mirror those observed in the general population during the course of this study. The pathways were also informed by a review of the literature and advice from clinical experts on the research team. The model combined estimates of probabilities relating to transitions between the models' health states, resource use/ cost, and the number of evacuations avoided in each arm.
Probabilities providing a quantitative estimate of the likelihood that a given event within the clinical pathways would occur were obtained from the NT Department of Health PCIS and are presented for both POCT and usual care arms (data supplied in Table S1 ).
Resource use and subsequent costs associated with both the POCT and usual care arms were estimated to calculate mean costs per patient for both arms (Table S2) . Total costs per patient were estimated by combining resource use data and unit costs for these resources (derived from published data sets including those from the NTHDW). Total costs per patient were calculated as the sum of staff costs (incurred when carrying out assessments and tests and undergoing training), equipment costs (including costs of the i-STAT device), and costs of supplies (eg, consumables such as i-STAT cartridges, syringes for blood sampling, gloves, and protective equipment). Drug costs (eg, morphine, clopidogrel, enoxaparin, calcium resonium, and lactulose) and treatment costs (eg, oxygen, saline, and oral hydration solutions), other submit your manuscript | www.dovepress.com In all models, "#" is 1 -the probability in the branch above; Medical evacuation, individual was medically evacuated; No medical evacuation, individual was not medically evacuated. Model A: Usual Care -Chest Pain, usual care arm for individuals with acute chest pain; ProbMedEvac_UsualCare_Chest, probability of being evacuated in the usual care arm; POCT -Chest Pain, point of care test arm for individuals with acute chest pain; Single cTnI test, pathway for individuals that have a single cardiac troponin I test within the POCT arm; Prob_SinglecTnI_test_Positive, probability of having a positive result from a single cTnI test; cTnI test positive, having a positive result from a single cTnI test; Prob_SinglecTnI_test_Positive, probability of having a positive result from a single cTnI test; cTnI test negative, having a negative result from a single cTnI test; ProbMedEvacAfterSingleNegTest, probability of being evacuated following a negative result from a single cTnI test; Repeat cTnI test, pathway for individuals that have a repeat cTnI test within the POCT arm; First cTnI test positive; having a positive result from the first of repeat cTnI test; Prob_RepeatcTnI_ test_FirstPositive, probability of having a positive result from the first of repeat cTnI tests; Repeat cTnI test positive, having a positive result on the second cTnI test; Prob_RepeatcTnI_test_FirstPositive_SecondPositive, probability of having two positive results from the repeat cTnI tests; Repeat cTnI test negative, having a negative result on the second cTnI test; ProbMedEvac_FirstPositive_SecondNegativeTest, probability of being evacuated following a positive and then a negative result from repeat cTnI tests; First cTnI test negative, having a negative result from the first of repeat cTnI test; Prob_RepeatcTnI_test_FirstNegative_SecondPositive, probability of having negative and then a positive result from the repeat cTnI tests; ProbMedEvac_FirstNegative_SecondNegativeTest, probability of being evacuated following two negative results from repeat cTnI tests. Model B: Usual Care -Dialysis, usual care arm for individuals with chronic renal failure who missed a dialysis session(s); ECG changes detected, pathway for individuals in whom ECG changes were detected; ProbMedEvac_UsualCare_Dialysis, probability of being evacuated following ECG changes being detected; No ECG changes detected, pathway for individuals in whom no ECG changes were detected; POCT -Dialysis, point of care test arm for individuals with chronic renal failure who missed a dialysis session(s); K+>6.5 mmol/L, pathway for individuals who had a positive potassium assay test result; ProbMedEvac_KplusGreaterThanSixPointFive_Dialysis, probability of being evacuated following a positive potassium assay test result; K+<6.5mmol/L, pathway for individuals who had a negative potassium assay test result; ProbMedEvac_ KplusLessThanSixPointFive_Dialysis, probability of being evacuated following a negative potassium assay test result. Model C: Usual Care -diarrhea, usual care arm for individuals with acute diarrhea and evidence of dehydration; Rehydration failure, pathway for individuals who had rehydration failure; ProbMedEvac_UsualCare_Diarrhea, probability of having rehydration failure in the usual care arm which is equal to the probability of being evacuated following rehydration failure in this arm; Rehydration success, pathway for individuals who had rehydration success; POCT -Diarrhea, point of care test arm for individuals with acute diarrhea and evidence of dehydration; Na+/ K+ test, sodium and potassium test used in the POCT arm; ProbMedEvac_UsualCare_Diarrhea, probability of having rehydration failure in the POCT arm which is equal to the probability of being evacuated following rehydration failure in this arm. 
Dovepress
272
Dovepress
Spaeth et al
Dovepress
273
Dovepress
POCT in remote Australian NT primary health care sector ongoing operational costs of conducting i-STAT testing and other clinical assessments, and costs of medical evacuations also formed part of the total costs. Equipment and training costs were annuitized at 5% and based on a conservative lifetime of 5 years. 20 An annual maintenance cost for equipment of $1,039 was also included in the costing. All resource costs used in the model are reported in Australian dollars at 2017/18 unit prices. The Supplementary materials provide a description of the resource use and data estimates split into pre-evacuation, evacuation, and prevalence estimates.
Economic evaluation
A patient-level analysis was undertaken from a health sector (Medicare) cost perspective and the results reported in terms of cost savings because of prevention of unnecessary medical evacuation. Probabilistic analyses were used in the base case and sensitivity analyses based on 100,000 Monte Carlo simulations. To facilitate the probabilistic analyses, beta distributions were used to model the probability of transitions between health states while gamma distributions were fitted to all costs.
The availability of estimates on the cost of a medical evacuation for a single patient (Table S3 ) enabled incremental cost savings due to medical evacuations avoided to be calculated. These savings were calculated as the average weighted round-trip cost of a medical evacuation times the number of unnecessary medical evacuations avoided less the incremental cost (Table S3) . Per patient incremental cost savings for each medical presentation were then extrapolated to the general NT population through multiplying them by the prevalence estimates for each respective medical presentation.
Sensitivity analysis for the economic evaluation was undertaken to assess uncertainty in the cost savings due to avoided medical evacuations by splitting the sample into Top End services (n=40 services) cost of per medical evacuation or Central Australian services (n=32 services) and applying the respective costs of medical evacuations for these services (Table S3) . Table 1 shows that the mean ± standard error costs per patient (presented for the usual care and POCT arms, respectively) were $257±1 and $341±1 (acute chest pain), $274±1 and $308±1 (missed dialysis), and $204±1 and $306±1 (acute diarrhea). The total cost of a round-trip medical evacuation was estimated as $22,560 per patient (data supplied in Table S3 ).
Results
A summary of the economic evaluation results provided in
Patients presenting with chest pain (without ST elevation on ECG)
Compared to usual care, POCT for patients with acute chest pain (POCT -Chest Pain) was more expensive (by $84 per patient; 95% confidence interval [CI]: $81-$86) but also more effective (prevented 0.2109 unnecessary medical evacuations per patient; 95% CI: 0.2106-0.2112, Table 1 ). Adopting the "POCT -Chest Pain" strategy and then spend- ing $34,097 per 100 patients, as opposed to $25,720 per 100 patients under the "Usual Care -Chest Pain" strategy, would lead to 21 unnecessary medical evacuations being avoided (Table 1) . Adopting the "POCT -Chest Pain" strategy in place of usual care would lead to cost savings (due to unnecessary medical evacuations avoided) of $4,674 per patient, translating to cost savings of $13.72 million per annum for the entire NT population (Table 2) based on an acute chest pain prevalence figure estimate of 2,936 for the NT in 2015.
Patients presenting with CRF/missed dialysis session(s)
POCT for patients with CRF who missed one or more dialysis sessions (POCT -Missed Dialysis) was more expensive (by $34 per patient; 95% CI: $32 to $36) than usual care for these patients (Usual Care -Missed Dialysis) but also more effective (prevented 0.3577 unnecessary medical evacuations per patient; 95% CI: 0.3572-0.3582). Adopting the "POCTMissed Dialysis" strategy and then spending $30,808 per 100 patients, as opposed to $27,370 per 100 patients under the "Usual Care -Missed Dialysis" strategy, would lead to 36 unnecessary medical evacuations being avoided (Table 1) . A decision to adopt POCT instead of usual care for patients who missed dialysis would lead to cost savings of $8,035 per patient, translating to cost savings of $6.45 million per annum for the entire NT population (Table 2) Patients presenting with acute diarrhea POCT for patients with acute diarrhea (POCT -Diarrhea) was more expensive than usual care for these patients (Usual Care -Diarrhea) by $102 per patient (95% CI: $100-$103) but also more effective (ie, this strategy prevented 0.04 unnecessary medical evacuations per patient; 95% CI: 0.0384-0.0403). Adopting the "POCT -Diarrhea" strategy and then spending $30,596 per 100 patients, as opposed to $20,438 per 100 patients under the "Usual Care -Diarrhea" strategy, would lead to four unnecessary medical evacuations being prevented (Table 1) . Adopting the "POCT -Diarrhea" strategy in place of usual care would lead to cost savings of $786 per patient, translating to cost savings of $1.57 million per annum for the entire NT population (Table 2) based on an acute diarrhea prevalence figure estimate of 2,001 for the NT in 2015.
Sensitivity analysis
In the sensitivity analyses, restricting the analysis to just the Top End services (n=40; cost per medical evacuation per patient=$25,491 as per Table S3 ) resulted in cost savings of $5,292 per patient for acute chest pain, $9,084 per patient for missed dialysis, and $901 per patient for acute diarrhea. The corresponding overall savings for these Top End services 
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POCT in remote Australian NT primary health care sector were $11.50 million, $3.24 million, and $1.23 million per annum (Table 2) . When the analysis focussed on Central Australian services (n=32; cost per medical evacuation per patient=$17,610 -as per Table S3 ), cost savings per patient were $3,630 (acute chest pain), $6,264 (missed dialysis), and $591 (acute diarrhea) leading to corresponding overall savings for these services of $2.77 million, $2.79 million, and $0.37 million per annum, respectively. No adverse events were recorded within 10 days of the initial presentation for patients who remained in the community.
Discussion
A recent international study highlighted the importance of conducting setting-specific cost-effectiveness studies for POCT and the need for clinicians, policymakers, and industry to address the gaps in knowledge base in this area. 22 This study is the first in Australia to provide a detailed economic evaluation of acute POCT in the remote primary care setting.
Within this setting, POCT was shown to deliver an estimated cost saving of $21.75 million because of prevention of unnecessary medical retrievals for the whole NT. In terms of clinical presentation, savings were greatest in the "chest pain" patient group ($13.72 million) compared to the savings in the "missed dialysis" ($6.45 million) and the "acute diarrhea" groups ($1.57 million). The differences in costs savings for Central Australia ($5.94 million) and Top End ($15.98 million) were due to differences in prevalence and total numbers of evacuations in these jurisdictions. Although the cost of delivering the POCT pathway per patient was slightly higher (by $84, $34, and $102, respectively) for the three clinical presentations than the usual care pathway, the cost savings in prevented evacuations far outweighed this small cost impost.
This research highlights that POCT can produce substantial cost savings, which significantly outweigh operational costs, through preventing unnecessary medical evacuations when used in the rural and remote health care setting, where access to timely pathology results is not available. These cost savings could be realized by other rural and remote jurisdictions nationally and internationally through adoption of quality-assured POCT networks to aid decision making for acute presentations with the additional benefit of increasing patient safety.
This study has some limitations. First, this research project did not investigate the additional in-hospital costs saved through preventing admission to a tertiary hospital. The effects of unnecessary medical evacuations on patient/ community (eg, loss of productivity or social or emotional wellbeing of Indigenous patients) were also not included in this study. However, an Australian report on the economic value of pathology found that troponin testing alone reduced the number of admissions to metropolitan emergency departments resulting in cost savings of ~$166.5 million per annum. 23 The same report also estimated that troponin testing enabled an early discharge strategy to be safely pursued for ~40% of patients with suspected ACS. 23 This finding is similar to the present study in which 38% of patients presenting with chest pain (and no ST-elevation) did not require an evacuation as a result of on-site troponin I testing on the i-STAT device. Therefore, including data on admissions prevented as well as broader costs and outcomes would most likely have made POCT even more cost-effective. Costs associated with keeping the patient in a remote health facility for monitoring were also not included in this study. These costs are, however, estimated to be minimal as no overnight stay beds are available in remote health clinics because of NT government policy.
Second, the clinical and cost effectiveness of POCT in this study was only examined for three common acute presentation types. A survey of clinical staff indicated that the i-STAT was also being used for additional acute presentations such as respiratory disorders and sepsis, as well as for the management of patients on anticoagulation therapy. The use of the i-STAT for these presentations is likely to provide additional clinical and cost benefits, which have not been part of this study. It is also noteworthy that the cost of administering the entire NT POCT Program, operational costs, and the cost of the i-STAT device (including servicing and maintenance) were calculated for all POCT conducted on the i-STAT device during the study period (including for example INR, blood gas, and lactate testing). A small percentage of evacuations in the NT are provided by helicopter (<5%); this mode of evacuation is extremely costly (~$16,167 per hour compared to $8,495 per hour for a fixedwing air evacuation) but was not factored into the economic evaluation because data on the number of helicopter evacuations were not able to be sourced from the Central Australian region; as a result, the total cost savings documented in this study may be slightly underestimated. The average per patient cost of using the i-STAT was calculated to be $58; however, the costs per patient varies depending on the number of patient tests performed on the i-STAT (for example, for one of the health centers servicing a smaller population in our study, the per patient cost of using the i-STAT test was $76.35, whereas for one of the larger centers the per patient cost was $31.58).
Finally, some of the sample sizes used in estimating the probabilities for the models were small and could, therefore, reduce the power of our analyses. Future research should consider replicating this analysis in bigger samples.
While the focus of this study was to examine the clinical and cost effectiveness of POCT for acute presentations, it also highlighted a major cultural benefit of POCT. The prevention of unnecessary medical retrievals enabled many patients to remain in their community, rather than having to suffer the social and emotional trauma associated with dislocation from their families by having to undergo an evacuation for further investigation to a tertiary institution.
Conclusion
Until now, the current literature from metropolitan tertiary settings indicated that, while POCT can generate improved clinical outcomes, it is generally more expensive than traditional laboratory pathology testing. However, little information is available on the economic effectiveness of POCT in remote settings, where POCT has a particular niche in providing access to critical pathology results in a timely manner. This study demonstrates that POCT can deliver significant cost savings (of the order of nearly AUD $22 million per annum) for the health care system through ruling out unnecessary and expensive emergency medical retrievals in remote Australia.
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